ARCHIVES

In Congress: Senate Bill Offers 13% Increase For NCI; house Provides 9%

This article is from The Cancer Letter archive.

Vol. 25 No. 38 | October 8, 1999

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978